{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:56:26Z","timestamp":1786136186970,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473248"],"award-info":[{"award-number":["82473248"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011176","name":"Peking Union Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijrobp.2026.07.004","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:04:43Z","timestamp":1784127883000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dose-Escalated Versus Standard Neoadjuvant Chemoradiation Therapy for Locally Advanced Rectal Cancer: Nine-Year Results of a Randomized Phase 2 Trial"],"prefix":"10.1016","author":[{"given":"Haoyue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongzhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yexiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 4","key":"10.1016\/j.ijrobp.2026.07.004_bib0001","doi-asserted-by":"crossref","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Glynne-Jones","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0002","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0003","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203","volume":"24","author":"G\u00e9rard","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0004","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0005","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0006","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijrobp.2012.05.017","article-title":"Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy","volume":"85","author":"Appelt","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0007","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0360-3016(00)00418-1","article-title":"Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer","volume":"47","author":"Janjan","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0008","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0360-3016(01)01540-1","article-title":"A phase I\/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma","volume":"50","author":"Myerson","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0009","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ijrobp.2006.05.063","article-title":"Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer","volume":"66","author":"Krishnan","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0010","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s10350-006-0678-z","article-title":"Preoperative chemoradiotherapy with concomitant small field boost irradiation for locally advanced rectal cancer: A multi-institutional phase II study (KROG 04-01)","volume":"49","author":"Kim","year":"2006","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0011","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/COC.0b013e318161dbd3","article-title":"Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: A phase II trial","volume":"31","author":"Ballonoff","year":"2008","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0012","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2011.07.030","article-title":"Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: A phase II trial","volume":"102","author":"Li","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0013","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/COC.0b013e31821a5844","article-title":"Neoadjuvant accelerated concomitant boost radiotherapy and multidrug chemotherapy in locally advanced rectal cancer: A dose-escalation study","volume":"35","author":"Caravatta","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0014","unstructured":"Trial of using SIB-IMRT in preoperative radiotherapy for locally advanced rectum cancer. ClinicalTrials.gov identifier: NCT02195141. Updated February 4, 2015. Accessed May 26, 2025. https:\/\/clinicaltrials.gov\/study\/NCT02195141"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0015","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ijrobp.2006.02.050","article-title":"Definition and delineation of the clinical target volume for rectal cancer","volume":"65","author":"Roels","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0016","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00066-011-0015-x","article-title":"Der ICRU-Report 83: Verordnung, dokumentation und kommunikation der fluenzmodulierten photonenstrahlentherapie (IMRT) [The ICRU Report 83: Prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT)]","volume":"188","author":"Hodapp","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0017","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0018","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1200\/JCO.2011.37.7176","article-title":"Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer","volume":"29","author":"Maas","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0019","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s003840050072","article-title":"Pathological features of rectal cancer after preoperative radiochemotherapy","volume":"12","author":"Dworak","year":"1997","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: Five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2014.08.035","article-title":"Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: A systematic review and meta-analysis","volume":"113","author":"Burbach","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0023","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijrobp.2005.07.969","article-title":"Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost","volume":"64","author":"Jakobsen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0024","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1200\/JCO.2005.03.6095","article-title":"Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012","volume":"24","author":"Mohiuddin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijrobp.2011.05.068","article-title":"Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer","volume":"83","author":"Engels","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0026","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00066-014-0650-0","article-title":"Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation","volume":"190","author":"Hernando-Requejo","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0027","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ijrobp.2013.02.020","article-title":"Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancer","volume":"86","author":"Mohiuddin","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0028","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818824367","article-title":"Preoperative volumetric modulated arc therapy with simultaneous integrated boost for locally advanced distal rectal cancer","volume":"18","author":"Yang","year":"2019","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0029","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13014-019-1420-z","article-title":"Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: A randomized, multicenter, phase II trial (FDRT-002)","volume":"14","author":"Wang","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.radonc.2018.11.023","article-title":"The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer","volume":"134","author":"Valentini","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0031","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13014-017-0894-9","article-title":"Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy\/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: A propensity score case-matched analysis","volume":"12","author":"Yamashita","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0032","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/medicina61030483","article-title":"Dose Escalation in neoadjuvant chemoradiotherapy for rectal cancer: Short-term efficacy and toxicity of VMAT-SIB vs. 3D-CRT","volume":"61","author":"Stojanovic-Rundic","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0033","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ijrobp.2020.06.013","article-title":"Efficacy of dose-escalated chemoradiation on complete tumor response in patients with locally advanced rectal cancer (RECTAL-BOOST): A phase 2 randomized controlled trial","volume":"108","author":"Couwenberg","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0034","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.21197","article-title":"Pathologic complete response and survival in rectal cancer: A systematic review and meta-analysis","volume":"8","author":"Sugumar","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0035","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm0806-875","article-title":"Is cancer a disease of self-seeding?","volume":"12","author":"Norton","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0036","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/cncr.11927","article-title":"The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer","volume":"100","author":"Jacob","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0037","doi-asserted-by":"crossref","DOI":"10.1111\/codi.17292","article-title":"Simultaneous integrated boost intensity-modulated radiation therapy targeting clinically involved extramesorectal lymph nodes in locally advanced rectal cancer: A retrospective study","volume":"27","author":"Nayak","year":"2025","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0038","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2013.10.026","article-title":"Preoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: Report on late toxicity and outcome","volume":"110","author":"Engels","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0039","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.annonc.2024.10.827","article-title":"A phase III randomised trial on the addition of a contact X-ray brachytherapy boost to standard neoadjuvant chemo-radiotherapy for organ preservation in early rectal adenocarcinoma: 5 year results of the OPERA trial","volume":"36","author":"Baron","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0040","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): A multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0041","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.5445","article-title":"Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: Long-term results of the CAO\/ARO\/AIO-12 randomized clinical trial","volume":"8","author":"Fokas","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0042","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0043","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1200\/JCO.18.02309","article-title":"Neoadjuvant modified FOLFOX6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: Final results of the Chinese FOWARC trial","volume":"37","author":"Deng","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.004_bib0044","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","article-title":"Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: Long-term results of the UNICANCER-PRODIGE 23 trial","volume":"35","author":"Conroy","year":"2024","journal-title":"Ann Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626039982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626039982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:28:05Z","timestamp":1786134485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626039982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":43,"alternative-id":["S0360301626039982"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.07.004","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-Escalated Versus Standard Neoadjuvant Chemoradiation Therapy for Locally Advanced Rectal Cancer: Nine-Year Results of a Randomized Phase 2 Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}